Selective application of axillary node dissection in elderly women with early breast cancer

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 652-659

  Aziz, Dalal ^a   Gardner, Sandra ^b   Pritchard, Kathleen ^a,b   Paszat, Lawrence ^a,b,c   Holloway, Claire M B ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Age; Axillary lymph node dissection; Breast cancer; SEER database; Survival

Indexed keywords

AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DATA ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGEON; TIME SERIES ANALYSIS;

AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 33846620589     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9092-y     Document Type: Article

References (24)

1. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567-75.
2. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 1999; 6:109-16.
3. Chua B, Ung O, Taylor R, Boyages J. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism? ANZ J Surg 2002; 72:786-92.
4. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999; 230:194-201.
5. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994; 73:664-7.
6. Mincey BA, Bammer T, Atkinson EJ, Perez EA. Role of axillary node dissection in patients with T1a and T1b breast cancer: Mayo Clinic experience. Arch Surg 2001 (July); 136:779-82.
7. Bourez R, Rutgers E, Van De Velde C. Will we need lymph node dissection at all in the future? Clin Breast Cancer 2002; 3:315-22.
8. Bohler F, Eiter H, Rhomberg W. Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated? Strahlenther Onkol 1998; 174:605-12.
9. Buchholz TA, Strom EA, McNeese MD, Hunt KK. Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer. Surg Clin N Am 2003; 83:911-30.
10. Reed DR, Lindsley SK, Mann GN, Austin-Seymour M, Korssjoen T, Anderson BO, Moe R. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 2005; 61:358-64.
11. Gelber RD, Cole BF, Goldhirsch A, Rose C, Fisher B, Osborne CK, Boccardo F, et al. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet 1996; 347:1066-71.
12. Flickinger D. Arm edema after lumpectomy and breast irradiation. Am J Clin Oncol 2003; 26:229-31.
13. Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN. Risk of arm lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003; 55:1209-15.
14. Chua B, Ung O, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J 2002; 8:15-22.
15. Truong PT, Bernstein V, Wai E, Chua B, Speers C, Olivotto IA. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Clin Invest 2002; 54:794-803.
16. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341:2061-7.
17. Feigelson BJ, Acosta JA, Feigelson HS, Findley A, Saunders EL. T1 breast carcinoma in women 70 years of age and older may not require axillary node dissection. Am J Surg 1996; 172:487-90.
18. Rosenbaum PR, Rubin DR. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984; 79:516-24.
19. Breast Cancer Versus Mastectomy. US General Accounting Office-Program Evaluation and Methodology Division Report #GAO/PEMB-95-9.
20. Snedecor GW, Cochran WG. Statistical Methods. Seventh Edition. The Iowa State University Press, Ames, Iowa 1980.
21. Du X, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer 2001; 92:730-7.
22. Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 2002; 94:1626-34.
23. Chua B, Ung O, Taylor R, Boyages J. Is information from axillary dissection relevant to patients with clinically node-negative breast cancer? Breast J 2003; 9:478-84.
24. Di Fronzo LA, Hansen NM, Stern SL, Brennan MB, Giuliano AE. Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer? Ann Surg Oncol 2000; 7:406-10.